Monday December 18th 2017

Clinical Efficacy of Delayed-Release Dimethyl Fumarate in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients with Highly Active Disease: An…

CONCLUSIONS: This analysis suggests that delayed-release DMF 240mg BID demonstrates clinical efficacy in RRMS patients with highly active disease. However, due to the small sample size, the results should be interpreted with caution.Study supported by: Biogen Idec, Inc.Disclosure: Dr. Hutchinson has received personal compensation for activities with Biogen Idec, Novartis, Bayer Schering, AbbVie, and Merck Serono. Dr. Hutchinson has received personal compensation in an editorial capacity for the Multiple Sclerosis Journal. Dr. Zhang has received personal compensation for activities with Biogen Idec. Ms. Yang has received personal compensation for activities with Biogen Idec as an employee. Ms. Yang holds stock and/or stock options in Biogen Idec. Ms. Yang has received research support from …

Source:  

Clinical Efficacy of Delayed-Release Dimethyl Fumarate in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients with Highly Active Disease: An…

Leave a Comment

More from category

MS Activists Celebrate 2017 State Policy Impact
MS Activists Celebrate 2017 State Policy Impact

/About-the-Society/News/MS-Activists-Celebrate-2017-State-Policy-Impact [Read More]

MS Research Program Funding Authorized by President Trump
MS Research Program Funding Authorized by President Trump

/About-the-Society/News/MS-Research-Program-Funding-Authorized-by-Presiden [Read More]

Germany’s Merck to make new bid to enter U.S. MS pill market
Germany’s Merck to make new bid to enter U.S. MS pill market

FRANKFURT (Reuters) - Germany's Merck KGaA is reviving plans to bring an oral multiple sclerosis (MS) treatment to the [Read More]

Researchers develop new method for quickly detecting signs of multiple sclerosis
Researchers develop new method for quickly detecting signs of multiple sclerosis

A METHOD for quickly detecting signs of multiple sclerosis has been developed by a University of Huddersfield research [Read More]

Terror survivors have increased risk of frequent migraine, tension headaches
Terror survivors have increased risk of frequent migraine, tension headaches

Survivors of a terror attack have an increased risk of frequent migraine and tension headaches after the attack, [Read More]